Dipeptidyl peptidase 4 (DPP-4) inhibitors
Sitagliptin and Metformin HCL
The FDA lists this product in 5 strengths and forms.
Composition
- Active ingredients
- SITAGLIPTIN, METFORMIN HYDROCHLORIDE 50MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SITAGLIPTIN, METFORMIN HYDROCHLORIDE 1000MG · TabletANDA218971-005 · Tentative approval
- SITAGLIPTIN, METFORMIN HYDROCHLORIDE 500MG · TabletANDA218971-003 · Tentative approval
- SITAGLIPTIN, METFORMIN HYDROCHLORIDE 1000MG ER TABLET · TabletANDA218971-001 · Tentative approval
- SITAGLIPTIN, METFORMIN HYDROCHLORIDE 50MG · TabletThis page
- SITAGLIPTIN, METFORMIN HYDROCHLORIDE EQ 100MG BASE TABLET · TabletANDA218971-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218971.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.